Hospital Acquired Infections Therapeutics Market: Innovations in Infection Control Solutions up to 2
The Hospital Acquired Infections (HAI) Therapeutics market comprises pharmaceutical treatments and therapies aimed at managing and combating infections contracted within healthcare facilities. These infections, including pneumonia, bloodstream infections, urinary tract infections, and surgical site infections, often occur due to prolonged hospital stays, invasive procedures, and the presence of antibiotic-resistant bacteria. HAI therapeutics focus on treatments that target specific pathogens commonly responsible for hospital-acquired infections and play a vital role in patient recovery and infection control within healthcare settings.